News

A Duke-led clinical trial is investigating whether treating MASH, an advanced form of fatty liver disease, can also improve heart health in patients with a form of early heart failure.

The woman had not spoken for months, advanced dementia having gradually robbed her of the ability to communicate or recognize loved ones. When she was admitted to the hospital with aspiration pneumonia, her family gathered to face the inevitable. A beloved granddaughter rushed across the country to say goodbye.

Duke researchers are investigating how a dangerous but under-recognized lipid disorder is identified and treated in real-world clinical practice.

A new study from Duke University School of Medicine has uncovered a surprising adaptation in Escherichia coli that may help explain why some bloodstream inf

Christopher Mosher, MD, assistant professor in the Division of Pulmonary, Allergy, and Critical Care Medicine and a faculty member within the Duke Clinical Research Institute (DCRI), has been named

Manesh Patel will serve as volunteer president and Svati Shah as president-elect to steer the organization’s mission to improve heart and brain health across the nation

Victor Ayeni, MD, a rising third year resident in Duke’s Internal Medicine Residency Program, is the bridge that connects fellow residents to new experiences and communities. “Relationships and service are just who I am, and that is a fundamental part of being a physician,” he said.

Anna Mae Diehl, MD, Florence McAlister Distinguished Professor of Medicine and director of the Duke Liver Center, has received the Rous-Whipple Award from the American